The breakeven issue in the AFR includes all the new product development and RnD, but the actual operating breakeven costs is around half of that ($275m) according to the prospectus.
Ann: Pre-Quotation Disclosure Notice With Various Confirmations, page-4
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DCL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.790M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DCL (ASX) Chart |
Day chart unavailable
